Studies of Patients With Skin Disease, Patients With Neurological Degenerations, and Normal Volunteers
NCT00001164 · Status: COMPLETED · Type: OBSERVATIONAL
Last updated 2008-03-05
Summary
It is proposed that patients with skin disease due to presumed immunologic, genetic or viral-induced abnormalities, patients with neurological degenerations, and normal controls be evaluated with various in vitro studies of immunologic, genetic, and virologic function. This is to include studies of peripheral blood (cells and serum) as well as studies of skin obtained with a biopsy instrument. In addition, studies of gastrointestinal function will be performed where appropriate.
Conditions
- Healthy
- Muscular Dystrophy
- Retinal Degeneration
- Skin Diseases
- Virus Diseases
Sponsors & Collaborators
-
National Cancer Institute (NCI)
lead NIH
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 1978-07-31
- Completion
- 2000-06-30
Countries
- United States
Study Locations
More Related Trials
-
Study and Treatment of Inflammatory Muscle Diseases
NCT00001265 ·Status: COMPLETED
-
Needs Assessment for Individuals and Families Affected by Dyskeratosis Congenita (DC) and Related Telomere Biology Disorders (TBD)
NCT04959188 ·Status: COMPLETED
-
Sensory Symptoms in Active Vitiligo
NCT05390164 ·Status: UNKNOWN
-
Methods Validation Assessment for Study of Inflammatory Skin Disease
NCT03796806 ·Status: COMPLETED
-
Study of Skin Tumors in Tuberous Sclerosis
NCT00001975 ·Status: RECRUITING
-
A Study of DR-01 in Subjects With Alopecia Areata and Vitiligo
NCT06602232 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Skin Biopsy Specimens as Biomarkers of Systemic Sclerosis and Response to Mycophenolate Mofetil
NCT00853788 ·Status: COMPLETED
-
Topical Sirolimus in Patients With Basal Cell Nevus Syndrome and in Healthy Participants
NCT00433485 ·Status: COMPLETED ·Phase: PHASE1
-
Identification of Cutaneous and Blood Biomarkers Predictive of Response to Systemic Treatments During Chronic Inflammatory Skin Diseases
NCT06599411 ·Status: NOT_YET_RECRUITING
-
Translational Assessment of Vitiligo According to Body Locations
NCT06068218 ·Status: COMPLETED ·Phase: NA
-
Examination of Clinical and Laboratory Abnormalities in Patients With Defective DNA Repair: Xeroderma Pigmentosum, Cockayne Syndrome, or Trichothiodystrophy
NCT00001813 ·Status: COMPLETED
-
Identifying Skin Biopsy Sites
NCT01632644 ·Status: COMPLETED
-
Assessment of Circulating Fubctional Mitochondrias in Vitiligo Patients
NCT05525741 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Establishment of the National Epidermolysis Bullosa Registry
NCT00004761 ·Status: COMPLETED
-
Predictive and Prognostic Biomarkers in Patients With Mycosis Fungoides and Sézary Syndrome.
NCT04904146 ·Status: RECRUITING
-
Validation of Cutaneous Nerve Demyelination in Diagnosis and Treatment of CIDP
NCT05614128 ·Status: TERMINATED
-
T Cell Repertoire Analysis of Immune Mediated Skin Diseases
NCT00368784 ·Status: COMPLETED
-
Validation of a Questionnaire to Identify Signs and Symptoms of Nephrogenic Systemic Fibrosis
NCT00869479 ·Status: COMPLETED
-
Assessment of Digital Imaging as a Tool for Diagnosing Psoriasis, Hand Rashes and Unusual Moles
NCT00005781 ·Status: COMPLETED
-
Metabolic Profiling of Immune Responses in Immune-mediated Diseases
NCT04864886 ·Status: RECRUITING
-
Efficacy of Granulocyte Colony Stimulating Factor (GCSF) In Patients With Dystrophic Epidermolysis Bullosa
NCT01538862 ·Status: COMPLETED ·Phase: PHASE2
-
Single Ascending Dose of FXI-GalNAc-siRNA in Healthy Subjects
NCT05844293 ·Status: RECRUITING ·Phase: PHASE1
-
Proof of Biological Activity of SAR100842 in Systemic Sclerosis
NCT01651143 ·Status: COMPLETED ·Phase: PHASE2
-
Study of the Efficacy, Safety & Tolerability of Serlopitant for Pruritus (Itch) After Burn Injury
NCT02975271 ·Status: TERMINATED ·Phase: PHASE2
-
Study of PTW-002 in Patients With Dominant or Recessive Dystrophic Epidermolysis Bullosa Due to Mutation(s) in Exon 73 of the COL7A1 Gene
NCT05529134 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2